You answer questions about your medical history, current medications, allergies, BMI, and weight loss goals
Oral formulations have a shorter half-life.[ref] In clinical trials, GLP-1 RAs improved lipid profiles, increased satiety, slowed gastric emptying, reduced inflammation, and had neuroprotective effects.[ref] The slowing of gastric emptying and reducing inflammation may play a role in weight loss, along with the decrease in appetite and eating less
Joint pain and tissue recovery: BPC-157 and TB-500 target musculoskeletal repair through complementary mechanisms
Cancer 91 , 5559 (2001)
Tirzepatide, which activates both GLP-1 and GIP receptors, may produce different effects compared to pure GLP-1 agonists